Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Efficacy, Safety of Ribociclib Plus Letrozole for ER+/HER2- Breast Cancer

Mattea Reinisch, MD, highlights the final efficacy and safety results of the phase 3b, multi-center, open label Ribecca trial for women with ER+, HER2- locally advanced or metastatic breast cancer, presented as a poster at the virtual SABCS meeting.

Advertisement

Advertisement

Advertisement

Advertisement